ASCO Annual Meeting (In Person)

Event description:

The 2023 ASCO Annual Meeting brings together one of the largest, most diverse audiences in global cancer care.

Novotech has experience in conducting approximately 750 oncology clinical trials across all phases. With this experience, Novotech, the leading Asia Pacific biotech specialist CRO, was proud to present “The Next Big Thing in Cancer Care” webinar in collaboration with eChinaHealth and the ASCO 2022 Breakthrough program committee earlier this year.

If you are considering APAC, US or Europe for your clinical trials, it would be a great opportunity to connect during the 2023 ASCO Annual Meeting to learn more about your plans and see if/how we can support your clinical development plans over 2023 and beyond. Australia is a very attractive destination for early phase clinical trials (43.5% cash rebate on clinical trial expenses, rapid start-up with no IND required)